Artelo Biosciences 주식 가격. ARTL - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

가격

1.18

매수가

1.13

매도가

1.24

거래량

11,993

1.17 일간 변동폭 1.2043

0.91 52주 범위 1.75

market_cap

3.809M

전일 종가

1.15

개장가

1.20

최근 거래 시간

1.23

마지막 거래 시간

재정 규모

US$ 14,190

VWAP

1.1832

평균 볼륨(3m)

34,614

발행 주식

3,227,700

배당수익률

주가수익률

-0.41

주당순이익(EPS)

-2.88

매출

순이익

-9.29M

Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approa... Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approaches to cannabinoid-based therapies, including those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds that promote the effectiveness of the endocannabinoid system. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease. 더 보기

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

www.artelobio.com

본부

Fernley, Nevada, USA

설립됨

Artelo Biosciences Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker ARTL. The last closing price for Artelo Biosciences was US$1.15. Over the last year, Artelo Biosciences shares have traded in a share price range of US$ 0.91 to US$ 1.75.

Artelo Biosciences currently has 3,227,700 shares in issue. The market capitalisation of Artelo Biosciences is US$3.71 million. Artelo Biosciences has a price to earnings ratio (PE ratio) of -0.41.

Artelo Biosciences Announces Successful Completion of First Cohort in a Phase 1 Study of ART26.12

The first selective Fatty Acid Binding Protein 5 inhibitor safely administered to human subjects Initial safety and pharmacokinetic data expected during the first half 2025 SOLANA BEACH, Calif...

Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia

SOLANA BEACH, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit

SOLANA BEACH, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium

SOLANA BEACH, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update

SOLANA BEACH, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form ARS - Annual Report to Security Holders

Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program

SOLANA BEACH, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th

SOLANA BEACH, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

SOLANA BEACH, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0.05	4.42477876106	1.13	1.21	1.12	21562	1.14848934	CS
4	0.2341	24.7489163759	0.9459	1.21	0.9459	27867	1.11948496	CS
12	0.03	2.60869565217	1.15	1.32	0.91	34614	1.13216284	CS
26	-0.24	-16.9014084507	1.42	1.44	0.91	20438	1.16149088	CS
52	-0.23	-16.3120567376	1.41	1.75	0.91	34886	1.30131476	CS
156	0.7788	194.117647059	0.4012	7.2	0.2599	227496	1.34088118	CS
260	-1.12	-48.6956521739	2.3	7.2	0.2599	1233639	1.40480707	CS

ARTL - Frequently Asked Questions (FAQ)

What is the current Artelo Biosciences share price?

The current share price of Artelo Biosciences is US$ 1.18

How many Artelo Biosciences shares are in issue?

Artelo Biosciences has 3,227,700 shares in issue

What is the market cap of Artelo Biosciences?

The market capitalisation of Artelo Biosciences is USD 3.71M

What is the 1 year trading range for Artelo Biosciences share price?

Artelo Biosciences has traded in the range of US$ 0.91 to US$ 1.75 during the past year

What is the PE ratio of Artelo Biosciences?

The price to earnings ratio of Artelo Biosciences is -0.41

What is the reporting currency for Artelo Biosciences?

Artelo Biosciences reports financial results in USD

What is the latest annual profit for Artelo Biosciences?

The latest annual profit of Artelo Biosciences is USD -9.29M

What is the registered address of Artelo Biosciences?

The registered address for Artelo Biosciences is 564 WEDGE LANE, FERNLEY, NEVADA, 89408

What is the Artelo Biosciences website address?

The website address for Artelo Biosciences is www.artelobio.com

Which industry sector does Artelo Biosciences operate in?

Artelo Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
ASSTAsset Entities Inc	US$ 0.8998 (93.71%)	262.98M
DWTXDogwood Therapeutics Inc	US$ 3.18 (70.05%)	24.28M
USEGUS Energy Corp	US$ 3.74 (61.21%)	107.77M
DOGZDogness International Corporation	US$ 27.62 (52.60%)	1.93M
MYNAMynaric AG	US$ 0.6697 (50.83%)	3.72M
GOEVCanoo Inc	US$ 0.3748 (-72.24%)	41.38M
SHOTWSafety Shot Inc	US$ 0.1094 (-47.40%)	18.06k
ORKTOrangeKloud Technology Inc	US$ 0.7068 (-36.89%)	7.48M
HEPAHepion Pharmaceuticals Inc	US$ 0.3219 (-31.36%)	1.66M
WNWMeiwu Technology Company Ltd	US$ 0.2681 (-27.05%)	11.02M
GCTKGlucoTrack Inc	US$ 0.1226 (44.41%)	613.28M
CRKNCrown Electrokinetics Corporation	US$ 0.1121 (-10.32%)	392.52M
ASSTAsset Entities Inc	US$ 0.8998 (93.71%)	262.98M
RIMEAlgorhythm Holdings Inc	US$ 0.034599 (-16.83%)	230.08M
RGTIRigetti Computing Inc	US$ 13.97 (42.12%)	226.81M